Last reviewed · How we verify
Std-dose iv MgSO4
Magnesium sulfate acts as an anticonvulsant and vasodilator by inhibiting neuronal excitability and promoting blood vessel dilation.
Magnesium sulfate acts as an anticonvulsant and vasodilator by inhibiting neuronal excitability and promoting blood vessel dilation. Used for Pre-eclampsia prevention and treatment, Seizure prophylaxis in eclampsia.
At a glance
| Generic name | Std-dose iv MgSO4 |
|---|---|
| Sponsor | Hamad Medical Corporation |
| Drug class | Anticonvulsant, Vasodilator |
| Target | Voltage-gated calcium channels |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular, Neurology |
| Phase | Phase 3 |
Mechanism of action
Magnesium sulfate's anticonvulsant properties are thought to be due to its ability to block voltage-gated calcium channels, reducing neuronal excitability and preventing seizures. Its vasodilatory effects are mediated through the relaxation of smooth muscle cells in blood vessels, leading to increased blood flow and decreased blood pressure.
Approved indications
- Pre-eclampsia prevention and treatment
- Seizure prophylaxis in eclampsia
Common side effects
- Flushing
- Dizziness
- Headache
- Nausea
- Vomiting
- Respiratory depression
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Std-dose iv MgSO4 CI brief — competitive landscape report
- Std-dose iv MgSO4 updates RSS · CI watch RSS
- Hamad Medical Corporation portfolio CI